Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Upgrades Enhance Dedicated Protein Purification System

By BiotechDaily International staff writers
Posted on 22 May 2013
A flexible and easily customizable protein purification system was designed to enable investigators to automate laborious and repetitive protein purification steps and allow them to concentrate on research applications of the purified sample.

The GE Healthcare (Uppsala, Sweden) ÄKTA Pure Protein Purification System is a flexible and intuitive chromatography platform for fast purification of proteins, peptides, and nucleic acids from microgram to gram levels of target product.

The latest generation of the ÄKTA Pure System boasts a new fraction collector that is covered to minimize contamination and supports flexible combinations of collection vessels from deep-well plates to 250 mL bottles.

In addition, a novel sample pump provides fast, automated, and complete loading of up to seven samples. The pump's integrated air-sensor detects the final drop of sample, automatically preventing the introduction of air while ensuring the complete sample reaches the column. The sample pump also has a robust wash program that removes any air introduced between samples.

The ÄKTA Pure Systems may be customized quickly and easily due to the modular design of both its hardware and software components. The operator is able to choose from more than 20 proven hardware options, and the system may be extended further by interfacing third-party add-ons such as detectors and autosamplers.

Related Links:

GE Healthcare



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: A leukemia cell coated with antibody is marked for destruction by activated natural killer cells (Photo courtesy of the University of Southern California).

Leukemia Cells Are Killed in Culture by Immune Cells Grown from the Same Patient

Immune system natural killer (NK) cells were isolated from leukemia patients, expanded in culture, and then shown in an in vitro system to attack and destroy cancer cells from the original cell donors.... Read more

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.